Description
Relugolix (brand name Relumina) is an oral gonadotropin-releasing hormone (GnRH) receptor antagonist medication. It is used to treat uterine fibroids and endometriosis in women, and prostate cancer in men.
Relugolix works by blocking the GnRH receptor, which prevents the pituitary gland from releasing luteinizing hormone (LH) and follicle-stimulating hormone (FSH). This leads to a decrease in sex hormone production, including testosterone in men and estrogen in women.
In women with uterine fibroids, relugolix can help to reduce the size of the fibroids and improve symptoms such as heavy menstrual bleeding, pelvic pain, and pressure. In women with endometriosis, relugolix can help to reduce pelvic pain and improve quality of life. In men with prostate cancer, relugolix can help to slow the growth and spread of the cancer.
Relugolix is taken once a day by mouth. It is typically started between the 1st and 5th day of the menstrual cycle in women. Relugolix is usually taken for up to 6 months, as prolonged use can lead to bone loss.
Common side effects of relugolix include:
- Menstrual irregularities
- Hot flashes
- Night sweats
- Headaches
- Decreased bone mineral density
Relugolix is a well-tolerated medication, but it is important to talk to your doctor about the risks and benefits before starting treatment.
Relugolix is a promising new treatment option for women with uterine fibroids and endometriosis, and for men with prostate cancer. It is important to note that relugolix is a prescription medication, and it is important to talk to your doctor to see if it is right for you.
Reviews
There are no reviews yet.